X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Middle East and South Asia

Technologies To Improve Patient Adherence And Trends In Pharmaceutical Manufacturing To Be Discussed By Catalent At CPhI North America

Content Team by Content Team
27th April 2019
in Middle East and South Asia, News
Catalent At CPhI North America

Catalent (booth 1206), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that its experts will participate in two conference sessions at the upcoming CPhI North America tradeshow at the Lakeside Center at McCormick Place, Chicago, on April 30 – May 2, 2019.

On Tuesday, April 30 at 9:45 a.m., Ronak Savla, Pharm.D., Ph.D., Scientific Affairs Manager, and co-chair of the Catalent Applied Drug Delivery Institute, has been invited to join the “Building a Better Drug: Strategies to Enhance Patient Drug Regimen” panel session. He will discuss roadblocks to patient adherence, and technologies and processes that can be employed to mitigate these problems including formulation methods, new dosage forms, excipients, and alternative delivery technologies.

On Wednesday, May 1 at 1:30 p.m., Mike Valazza, Vice President, Business Development, Oral Drug Delivery North America, will present “Advancements in Manufacturing Solutions”. His presentation will discuss current trends in pharmaceutical manufacturing, including the increase in the number of expedited programs, the need for integrated end-to-end solutions from Phase 1 to commercialization, and the adoption of technologies to assist in getting products to market faster.

Dr. Savla is responsible for the strategy of the scientific communications plan, management of external collaborations, scientific assessment of novel drug delivery technologies, oversight of internal technology development, and leadership of Catalent’s Scientific Excellence Initiative. He leads several initiatives within the company focusing on patient-focused drug design, including a collaboration with Rutgers University School of Pharmacy to investigate the challenges in pediatric dose form design. He received both his Doctor of Pharmacy degree and his doctorate from Rutgers University, New Brunswick, New Jersey.

Mr. Valazza has over 20 years’ experience in the pharmaceutical industry. Prior to joining Catalent in 2001, he held senior positions at several companies including International Processing Corporation, Glatt Air Techniques and Schering Pharmaceuticals. Mr. Valazza is a registered pharmacist, and a member of a variety of professional organizations including the American Pharmaceutical Association, the American Association of Pharmaceutical Scientists, and the Controlled Release Society. He received a bachelor’s degree in pharmacy from Rutgers University, New Brunswick, New Jersey.

At the show, Catalent executives will be available to discuss the recently announced acquisition of Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies, and will also share news of further network expansions. Catalent will be exhibiting and showcasing its multiple innovative technologies, and will host a bourbon tasting networking reception at Drumbar on Wednesday, May 1 at 7:30 p.m

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With more than 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal year 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com.

Previous Post

Catalent Collaborates With MGB Biopharma To Provide Accelerated Formulation And Supply Services For Phase 2 Clinical Trial

Next Post

On-Metal RFID tags enable 100% retail inventory tagging

Related Posts

Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Next Post
retail inventory tagging

On-Metal RFID tags enable 100% retail inventory tagging

Latest News

Cathay Cargo signs global airline partnership with Tower Cold Chain
Packaging & Logistic

Cathay Cargo signs global airline partnership with Tower Cold Chain

31st March 2023
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform
Facilities & Operation

£277m Funding Set To Benefit UK Life Sciences Manufacturing

31st March 2023
Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In